Journals / Ağrı / 2015 / Cilt: 27 - Sayı: 2

İdiyopatik intrakraniyal hipertansiyonun -diğer adıyla psödotümör serebrinin- patofizyolojisi üzerine bir güncelleme

An update on the pathophysiology of idiopathic intracranial hypertension alias pseudotumor cerebri

Journal
Ağrı
Pages
63–72
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Te aim of this review was to discuss the new insights on the mysterious pathogenesis of IIH.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Idiopathic intracranial hypertension (IIH) is a syndrome characterized by increased intracranial pressure of unknown cause, leading to severe headache, papilledema and visual disturbances.
📊
Key Findings & Data:Its former name, pseudotumor cerebri, has gained popularity recently.
💡
Conclusion & Impact:Te aim of this review was to discuss the new insights on the mysterious pathogenesis of IIH.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Idiopathic intracranial hypertension (IIH) is a syndrome characterized by increased intracranial pressure of unknown cause, leading to severe headache, papilledema and visual disturbances. Its former name, pseudotumor cerebri, has gained popularity recently. Te strongest and most consistent risk factors of IIH are obesity and female gender. Infrequently, IIH may present in the absence of papilledema showing a headache profle similar to chronic daily headache with migrainous features. Tere have been several proposed mechanisms to explain the etiology of this disorder associated with various clinical conditions. In recent years, some infammatory factors, natriuretic peptides and aquaporins have been proposed as possible contributors of the pathogenesis. On the other hand, some investigators have reported that bilateral transverse sinus stenosis is seen in the majority of IIH patients; therefore, dural sinus stent placement is used in some patients. No single theory has been able to provide a comprehensive answer, and there is no consensus about the exact cause of IIH. Te aim of this review was to discuss the new insights on the mysterious pathogenesis of IIH.

Özet

İdiyopatik intrakraniyal hipertansiyon (İİH) şiddetli başağrısı, papilödem ve görme bozukluklarına yol açan, nedeni bilinmeyen int- rakraniyal basınç artışı ile karakterize bir sendromdur. Eskiden kullanılan psödotümör serebri tanımı son yıllarda yeniden gündeme gelmiştir. İdiyopatik intrakraniyal hipertansiyon için en tutarlı ve en güçlü risk faktörleri obezite ve kadın cinsiyettir. Nadiren İİHde papilödem görülmeyip, başağrısı migrenöz özellikler taşıyan kronik günlük başağrısı profli gösterebilir. Farklı klinik durumlarla birlikteliği görülen bu durumun etiyolojisini açıklamaya yönelik çeşitli mekanizmalar öne sürülmüştür. Son yıllarda, enfamatuvar etmenler, natriüretik peptitler ve akuaporinlerin pathogeneze katkı olasılıkları üzerinde durulmaktadır. Öte yandan bazı araştırıcı- lar, İİH hastalarının çoğunda iki yanlı transvers sinüs darlığı görüldüğünü bildirmiş, bu nedenle de bazı hastalarda dural sinüslere stent yerleştirilmiştir. Görüldüğü gibi tek bir kuram bu sendromla ilgili soruları açıklamaya yetmemektedir ve İİHnin kesin nedeni üzerinde görüş birliği sağlanamamıştır. Bu derlemenin amacı, İİHnin gizemli patogenezi üzerine yeni gelişen görüşleri tartışmaktır.

🔖

Cite This Article

BAYKAN, B., TURGUT, E. E., ALTIOKKA, G. U. (2015). İdiyopatik intrakraniyal hipertansiyonun -diğer adıyla psödotümör serebrinin- patofizyolojisi üzerine bir güncelleme. Ağrı, Cilt: 27 - Sayı: 2, 63–72. https://ajindex.com/articles/351442

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol 1989;46(10):1049-51
  2. Cigeroglu OB, Gokyigit A, Baykan-Kurt B, Çelik M, Oge AE. Pseudotumour cerebri: Review of 34 cases. (in Turkish). Ar- chives of Neuropsychiatry 1994;31(1):57-62
  3. F riedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013;81(13):1159-65
  4. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotu - mor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988;45(8):875-7
  5. Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Ger- ryo SE. Epidemiology of idiopathic intracranial hyperten- sion: a prospective and case-control study. J Neurol Sci 1993;116(1):18-28
  6. Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O’Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993;50(1):78-80
  7. Kesler A, Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 2001;21(1):12-4
  8. P hillips PH, Repka MX, Lambert SR. Pseudotumor cerebri in children. J AAPOS 1998;2(1):33-8
  9. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114 (Pt 1A):155-80
  10. Headache Classifca tion Subcommittee of the International Headache Society. The International Classifcation of Head- ache Disorders: 2nd ed. Cephalalgia 2004;24(Suppl 1):9- 160
  11. Ek izoglu E, Baykan B, Orhan EK, Ertas M. The analysis of allo- dynia in patients with idiopathic intracranial hypertension. Cephalalgia 2012;32(14):1049-58
  12. Bono F, Quattrone A. Idiopathic intracranial hypertension without papilloedema in headache suferers. Cephalalgia 2009;29(5):594
  13. M arcelis J, Silberstein SD. Idiopathic intracranial hyperten - sion without papilledema. Arch Neurol 1991;48(4):392-9
  14. Vieira DS, Masruha MR, Gonçalves AL, Zukerman E, Senne Soares CA, Nafah-Mazzacoratti Mda G, et al. Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia 2008;28(6):609-13
  15. M athew NT, Ravishankar K, Sanin LC. Coexistence of mi- graine and idiopathic intracranial hypertension without papilledema. Neurology 1996;46(5):1226-30
  16. Dig re KB, Nakamoto BK, Warner JE, Langeberg WJ, Bag - galey SK, Katz BJ. A comparison of idiopathic intracranial hypertension wit